Bioactive Materials,
Journal Year:
2023,
Volume and Issue:
32, P. 445 - 472
Published: Oct. 26, 2023
Effective
tumor
treatment
depends
on
optimizing
drug
penetration
and
accumulation
in
tissue
while
minimizing
systemic
toxicity.
Nanomedicine
has
emerged
as
a
key
solution
that
addresses
the
rapid
clearance
of
free
drugs,
but
achieving
deep
into
solid
tumors
remains
elusive.
This
review
discusses
various
strategies
to
enhance
penetration,
including
manipulation
microenvironment,
exploitation
both
external
internal
stimuli,
pioneering
nanocarrier
surface
engineering,
development
innovative
tactics
for
active
penetration.
One
outstanding
strategy
is
organelle-affinitive
transfer,
which
exploits
unique
properties
specific
cell
organelles
heralds
potentially
transformative
approach
transcellular
transfer
Rigorous
models
are
essential
evaluate
efficacy
these
strategies.
The
patient-derived
xenograft
(PDX)
model
gaining
traction
bridge
between
laboratory
discovery
clinical
application.
However,
journey
from
bench
bedside
nanomedicines
fraught
with
challenges.
Future
efforts
should
prioritize
deepening
our
understanding
nanoparticle-tumor
interactions,
re-evaluating
EPR
effect,
exploring
novel
nanoparticle
transport
mechanisms.
Molecular Cancer,
Journal Year:
2023,
Volume and Issue:
22(1)
Published: March 11, 2023
The
malignant
tumor
is
a
multi-etiological,
systemic
and
complex
disease
characterized
by
uncontrolled
cell
proliferation
distant
metastasis.
Anticancer
treatments
including
adjuvant
therapies
targeted
are
effective
in
eliminating
cancer
cells
but
limited
number
of
patients.
Increasing
evidence
suggests
that
the
extracellular
matrix
(ECM)
plays
an
important
role
development
through
changes
macromolecule
components,
degradation
enzymes
stiffness.
These
variations
under
control
cellular
components
tissue
via
aberrant
activation
signaling
pathways,
interaction
ECM
to
multiple
surface
receptors,
mechanical
impact.
Additionally,
shaped
regulates
immune
which
results
suppressive
microenvironment
hinders
efficacy
immunotherapies.
Thus,
acts
as
barrier
protect
from
supports
progression.
Nevertheless,
profound
regulatory
network
remodeling
hampers
design
individualized
antitumor
treatment.
Here,
we
elaborate
on
composition
ECM,
discuss
specific
mechanisms
remodeling.
Precisely,
highlight
impact
development,
proliferation,
anoikis,
metastasis,
angiogenesis,
lymphangiogenesis,
escape.
Finally,
emphasize
"normalization"
potential
strategy
for
anti-malignant
Journal of Clinical Investigation,
Journal Year:
2022,
Volume and Issue:
132(11)
Published: May 31, 2022
Hypoxia-inducible
factors
(HIFs)
are
master
regulators
of
oxygen
homeostasis
that
match
O2
supply
and
demand
for
each
the
50
trillion
cells
in
adult
human
body.
Cancer
co-opt
this
homeostatic
system
to
drive
cancer
progression.
HIFs
activate
transcription
thousands
genes
mediate
angiogenesis,
stem
cell
specification,
motility,
epithelial-mesenchymal
transition,
extracellular
matrix
remodeling,
glucose
lipid
metabolism,
immune
evasion,
invasion,
metastasis.
In
Review,
mechanisms
consequences
HIF
activation
presented.
The
current
status
future
prospects
small-molecule
inhibitors
use
as
therapeutics
discussed.
International Journal of Molecular Sciences,
Journal Year:
2021,
Volume and Issue:
23(1), P. 146 - 146
Published: Dec. 23, 2021
Cancer
progression
with
uncontrolled
tumor
growth,
local
invasion,
and
metastasis
depends
largely
on
the
proteolytic
activity
of
numerous
matrix
metalloproteinases
(MMPs),
which
affect
tissue
integrity,
immune
cell
recruitment,
turnover
by
degrading
extracellular
(ECM)
components
releasing
matrikines,
surface-bound
cytokines,
growth
factors,
or
their
receptors.
Among
MMPs,
MMP-14
is
driving
force
behind
destruction
during
cancer
invasion
metastasis.
also
influences
both
intercellular
as
well
cell-matrix
communication
regulating
many
plasma
membrane-anchored
proteins.
cells
other
stroma,
embedded
in
a
common
matrix,
interact
means
various
adhesive
structures,
particularly
invadopodia
are
capable
to
remodel
through
spatially
temporally
finely
tuned
proteolysis.
As
deeper
understanding
underlying
functional
mechanisms
beneficial
for
development
new
prognostic
predictive
markers
targeted
therapies,
this
review
examined
current
knowledge
interplay
MMPs
context
protein,
subcellular,
cellular
level
focus
MMP14.
Pharmacological Reviews,
Journal Year:
2022,
Volume and Issue:
74(3), P. 714 - 770
Published: June 23, 2022
The
first
matrix
metalloproteinase
(MMP)
was
discovered
in
1962
from
the
tail
of
a
tadpole
by
its
ability
to
degrade
collagen.
As
their
name
suggests,
metalloproteinases
are
proteases
capable
remodeling
extracellular
matrix.
More
recently,
MMPs
have
been
demonstrated
play
numerous
additional
biologic
roles
cell
signaling,
immune
regulation,
and
transcriptional
control,
all
which
unrelated
degradation
In
this
review,
we
will
present
milestones
major
discoveries
MMP
research,
including
various
clinical
trials
for
use
inhibitors.
We
discuss
reasons
behind
failures
most
inhibitors
treatment
cancer
inflammatory
diseases.
There
still
misconceptions
about
pathophysiological
best
strategies
inhibit
detrimental
functions.
This
review
aims
preclinical
models
human
pathologies.
new
biochemical
tools
track
proteolytic
activity
vivo
ex
vivo,
addition
future
pharmacological
alternatives
functions
Significance
Statement
Matrix
(MMPs)
implicated
inflammatory,
autoimmune,
cancers,
pathogen-mediated
Initially
overlooked,
contributions
can
be
both
beneficial
disease
progression
resolution.
Thousands
substrates
suggested,
few
hundred
validated.
After
more
than
60
years
there
remain
intriguing
enigmas
solve
regarding
biological
Molecular Cancer,
Journal Year:
2022,
Volume and Issue:
21(1)
Published: Nov. 2, 2022
Tumors
are
comprised
of
both
cancer
cells
and
surrounding
stromal
components.
As
an
essential
part
the
tumor
microenvironment,
stroma
is
highly
dynamic,
heterogeneous
commonly
tumor-type
specific,
it
mainly
includes
noncellular
compositions
such
as
extracellular
matrix
unique
cancer-associated
vascular
system
well
a
wide
variety
cellular
components
including
activated
fibroblasts,
mesenchymal
cells,
pericytes.
All
these
elements
operate
with
each
other
in
coordinated
fashion
collectively
promote
initiation,
progression,
metastasis
therapeutic
resistance.
Over
past
few
decades,
numerous
studies
have
been
conducted
to
study
interaction
crosstalk
between
neoplastic
cells.
Meanwhile,
we
also
witnessed
exponential
increase
investigation
recognition
critical
roles
solid
tumors.
A
series
clinical
trials
targeting
launched
continually.
In
this
review,
introduce
discuss
current
advances
understanding
various
their
cancers.
We
elaborate
on
potential
novel
approaches
for
tumor-stroma-based
targeting,
aim
leap
from
bench
bedside.
Nature Communications,
Journal Year:
2022,
Volume and Issue:
13(1)
Published: Aug. 6, 2022
The
tumour
stroma,
and
in
particular
the
extracellular
matrix
(ECM),
is
a
salient
feature
of
solid
tumours
that
plays
crucial
role
shaping
their
progression.
Many
desmoplastic
including
breast
cancer
involve
significant
accumulation
type
I
collagen.
However,
recently
it
has
become
clear
precise
distribution
organisation
molecules
such
as
collagen
equally
important
abundance.
Cancer-associated
fibroblasts
(CAFs)
coexist
within
tissues
play
both
pro-
anti-tumourigenic
roles
through
remodelling
ECM.
Here,
using
temporal
proteomic
profiling
decellularized
tumours,
we
interrogate
evolving
matrisome
during
We
identify
4
key
matrisomal
clusters,
pinpoint
XII
critical
component
regulates
organisation.
Through
combining
our
proteomics
with
single-cell
transcriptomics,
genetic
manipulation
models,
show
how
CAF-secreted
alters
to
create
pro-invasive
microenvironment
supporting
metastatic
dissemination.
Finally,
patient
cohorts
may
represent
an
indicator
patients
at
high
risk
relapse.
Nature Communications,
Journal Year:
2022,
Volume and Issue:
13(1)
Published: Dec. 7, 2022
Abstract
Intratumor
heterogeneity
may
result
from
the
evolution
of
tumor
cells
and
their
continuous
interactions
with
microenvironment
which
collectively
drives
tumorigenesis.
However,
an
appearance
cellular
molecular
creates
a
challenge
to
define
features
linked
malignancy.
Here
we
perform
multiregional
single-cell
RNA
sequencing
(scRNA-seq)
analysis
seven
liver
cancer
patients
(four
hepatocellular
carcinoma,
HCC
three
intrahepatic
cholangiocarcinoma,
iCCA).
We
identify
dynamics
malignant
communication
networks
tumor-associated
immune
cells,
are
validated
using
additional
scRNA-seq
data
25
12
iCCA
as
stable
fingerprint
embedded
in
ecosystem
representing
aggressiveness.
further
validate
top
ligand-receptor
interaction
pairs
(i.e.,
LGALS9-SLC1A5
SPP1-PTGER4
between
macrophages)
associated
unique
transcriptome
542
patients.
Our
study
unveils
ecosystems,
open
path
for
therapeutic
exploration.